English version  
MIT
MIT
 
Injection Accueil Produits Recherche  et  Dev./F.A.Q Nouvelles À propos de nous Contactez-nous

Medical International Technology Inc. is pleased to announce that it has received clearance by
FINRA to be listed on the OTC Bulletin Board "MDLH.OB"
Thursday, January 14th 2010

DENVER, CO, Jan. 14 /PRNewswire-FirstCall/ - Medical International Technology Inc. (MDLH.OB) (www.mitcanada.ca), MIT is pleased to announce that it has received clearance by FINRA to be traded on the OTC Bulletin Board.

MIT's shares will be posted for trading on the OTC Bulletin Board at the opening of business, January 14, 2010, under the ticker symbol MDLH.OB.

This is very positive news for all existing and future shareholders. For the past 2 years, and during this difficult economic time, we have strived and did our utmost efforts to keep the company in good standing. MIT's current and future growth will require a strong, cohesive management and advisory team. The President of MIT, Mr. Karim Menassa, intends to build this strong team in the very near future.

Medical International Technology Inc. is proud to continue providing a safe and effective means to help prevent the spread of deadly diseases to both humans and animals through the use of the Med-Jet(R) and Agro-Jet(R) needle-free injection system.

About Medical International Technology, Inc. MIT CANADA, with offices in Montreal, is a subsidiary of Denver, Colorado-based Medical International Technology, Inc. (MIT USA), which specializes in the development, production, marketing and sale of needle-free injectors both for humans and animals, for individual and mass vaccinations.

The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development and acquisition of new product lines and services, government approval processes, the impact of competitive products or pricing a technological changes, the effect of economic conditions and other uncertainties, and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. Medical International Technology Inc. takes no obligation to update or correct forward-looking statements.


 
Medical International Technology, Inc.
 




Poland Japan Taiwan Korea Finland Greece Czech Republic Sweden Denmark France Canada Montana